陇神戎发 reported revenue of ¥0.33B for the period ended 2026-06-30, -31.0% year on year. Net income was ¥0.02B, a 7.2% net margin on a 64.6% gross margin. The largest revenue line is 药品销售 at 90% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.33B | -31.0% |
| Gross profit | ¥0.21B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.02B | -29.5% |
| Gross margin | 64.6% | Net margin 7.2% |
| Revenue Q/Q | -56.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 药品销售 | ¥0.30B | 89.6% |
| 医疗器械及其他 | ¥0.02B | 6.2% |
| 材料销售 | ¥0.01B | 2.3% |
| 房屋租赁 | ¥0.00B | 1.2% |
| 服务费收入及其他 | ¥0.00B | 0.3% |
| 检验检测 | ¥0.00B | 0.3% |
| 技术服务 | ¥0.00B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.12B | 35.4% |
| R&D | ¥0.01B | 3.3% |
| SG&A | ¥0.16B | 49.0% |
| Tax & other | ¥0.01B | 4.4% |
| Item | Amount |
|---|---|
| Total assets | ¥1.32B |
| Total liabilities | ¥0.52B |
| Shareholders' equity | ¥0.80B |
| Equity / assets | 60.7% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | -59% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
达威股份 ・ 农尚环境 ・ 广信材料 ・ 同益股份 ・ 横河精密 ・ 蜀道装备 ・ 先进数通 ・ 新晨科技 ・ 朗科智能 ・ 联得装备 ・ 雄帝科技 ・ 川环科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies